PRESS RELEASE

October 13, 2008

Anhydro launches an Advanced Pharmaceutical Spray Dryer for Aseptic and High Containment Processing.

The recently launched Spray Dryer MicraSpray (MS) 35 has now been further developed, conforming to regulatory requirements for truly aseptic production of sterile pyrogen-free powders. Applications include processing Biotechnology products and other novel drug compounds.

The innovative design of the MicraSpray 35 Aseptic includes sterilizing drying gas filtration, sterilization and depyrogenation in place by means of hot dry gas, assisted by conductive heating and selective steam sterilization. The compact design of the MicraSpray 35 facilitates the use of isolator technology to create a sterile process environment and provide high-containment operator protection.

According to Anhydro Technology Manager Robert Turok, Anhydro Aseptic Spray drying technology offers a number of benefits compared to lyophilization. Injectable powders can now be produced, enhancing particle morphology and flow characteristics by controlling particle size and shape, using a fast, continuous and robust process with lower installation and operating costs.

Products already processed using Aseptic Spray Drying technologies include vaccines, proteins/peptides, antibiotics, plasma volume replacements, and dry forms of contrast liquids.

Anhydro offers extensive test facilities including the new MicraSpray 35 and larger Spray Dryers for scale-up, both in Maryland USA and Copenhagen Denmark. Please visit www.anhydro.com for further information. Anhydro Group announces structural modifications to implement their next level worldwide strategy.